In Good Company

Merck’s Peter Guenter is seeking the next moonshot in cancer research

Mr Peter Guenter, 60, is the chief executive of Merck Healthcare. His father and grandfather were both doctors. ST PHOTO:JASON QUAH
Gift this subscriber-only story to your friends and family

Sometimes when Mr Peter Guenter addresses company town halls, he asks those in the audience who have lost a loved one to severe disease in the past five years to rise in their seats.

Nine in ten stand up.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Follow ST on LinkedIn and stay updated on the latest career news, insights and more.